Antiplatelets prescribed at discharge for heart bypass (CABG) surgery patients

A heart bypass surgery, also known as coronary artery bypass graft (CABG) surgery, creates a detour or bypass around the blocked or diseased portion of the coronary artery using an artery or vein from the body to restore the blood supply to the heart muscle.

Use of antiplatelet medications, such as aspirin, is associated with a reduced risk of death and complications, such as blood clot formation, following coronary artery bypass graft (CABG) surgery. 

About this measure

This measure tracks the percentage of patients who in 2011 had a CABG surgery and were prescribed an antiplatelet medication at discharge from the hospital.
Note: In this case, a higher number is better.
Most Recent Available Data (Percent)
Northwestern Memorial 100
National Database Participant Comparison 98.6
Source:Society of Thoracic Surgeons,
Isolated CABG antiplatelet at discharge